New Novozymes exec to halt bleeding in struggling growth division

A priority for Novozymes Executive Vice President Tine Sejersgård Fanø is to halt the bleeding which has rendered the growth field of bioethanol a deep disappointment.

Photo: Novozymes/ PR

2017 will be a fateful year for Novozymes, with critical focus on restoring investor confidence in the company.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from EnergyWatch

Further reading

Related articles

Latest News

See all jobs